Triangle Capital Corporation  

(Public, NYSE:TCAP)   Watch this stock  
Find more results for TCAP
-0.03 (-0.11%)
Apr 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 26.10 - 26.37
52 week 25.47 - 30.42
Open 26.33
Vol / Avg. 139,553.00/250,839.00
Mkt cap 730.09M
P/E 8.89
Div/yield 0.15/8.25
EPS 2.94
Shares 27.88M
Beta 0.76
Inst. own 32%
May 8, 2014
Q1 2014 Triangle Capital Corp Earnings Conference Call - 9:00AM EDT - Add to calendar
May 7, 2014
Q1 2014 Triangle Capital Corp Earnings Release - 4:00PM EDT - Add to calendar
May 7, 2014
Triangle Capital Corp Annual Meeting of Stockholders - 8:30AM EDT - Add to calendar
Feb 27, 2014
Q4 2013 Triangle Capital Corp Earnings Conference Call
Feb 26, 2014
Q4 2013 Triangle Capital Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 80.81% 80.39%
Operating margin 60.22% 60.49%
EBITD margin - 80.97%
Return on average assets 8.79% 10.09%
Return on average equity 16.07% 18.82%
Employees 25 -
CDP Score - -


Suite 530, 3700 Glenwood Avenue
United States - Map
+1-919-7194770 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Triangle Capital Corporation is a specialty finance company that provides customized financing solutions to lower middle market companies located throughout the United States. The Company operates as a non-diversified investment company. Its business is to provide capital to lower middle market companies in the United States. Its investment objective is to seek returns by generating current income from its debt investments and capital appreciation from its equity related investments. It invests primarily in subordinated debt securities secured by second lien security interests in portfolio company assets. On a more limited basis, it also invests in senior debt securities secured by first lien security interests in portfolio companies. Effective January 23, 2014, Triangle Capital Corp acquired an undisclosed minority stake in Danville Materials Inc, a manufacturer and wholesaler of dental equipment and supplies.

Officers and directors

Garland S. Tucker III Chairman of the Board, Chief Executive Officer
Age: 65
Bio & Compensation  - Reuters
E. Ashton Poole President, Chief Operating Officer, Director
Age: 46
Bio & Compensation  - Reuters
Steven C Lilly Chief Financial Officer, Chief Compliance Officer, Treasurer, Secretary, Director
Age: 43
Bio & Compensation  - Reuters
Brent P. W. Burgess Chief Investment Officer, Director
Age: 47
Bio & Compensation  - Reuters
W. McComb Dunwoody Independent Director
Age: 60
Bio & Compensation  - Reuters
Mark M. Gambill Independent Director
Age: 62
Bio & Compensation  - Reuters
Benjamin S. Goldstein Independent Director
Age: 57
Bio & Compensation  - Reuters
Simon B. Rich Jr. Independent Director
Age: 68
Bio & Compensation  - Reuters
Sherwood H. Smith Jr. Independent Director
Bio & Compensation  - Reuters